monjaro tirzepatide Mounjaro (tirzepatide) for the Treatment of Type 2 Diabetes, USA Tirzepatide's Association With BP Reduction

The short answer is yes, but timing and individual factors matter

Traveling with a tirzepatide pen requires planning but is completely permitted by TSA and international authorities

GLP-1 agonists are FDA-approved medications prescribed by healthcare providers for type 2 diabetes and chronic weight management

GLP-1 medications may offer benefits beyond weight loss and diabetes management, including better outcomes for breast cancer patients who are obese or have type 2 diabetes, according to new research.

Seventy-two week outcomes from the SURMOUNT-5 clinical trial have shown that tirzepatide (Zepbound) met the primary endpoint and all five key secondary endpoints, demonstrating superiority, compared to semaglutide (Wegovy) across the trial.The detailed results were presented at the 32nd European Congress on Obesity (ECO) and simultaneously published in The New England Journal of Medicine.SURMOUNT-5 was a 72-week, multi-centre, randomised, open-label, Phase 3b trial evaluating the efficacy and